Frontier Capital Management CO LLC Kymera Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.73 Billion
- Q4 2024
A detailed history of Frontier Capital Management CO LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 150,172 shares of KYMR stock, worth $5.53 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
150,172
Previous 392,263
61.72%
Holding current value
$5.53 Million
Previous $18.6 Million
67.46%
% of portfolio
0.06%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.5MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$253 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$221 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$195 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$190 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$190 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.01B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...